Proposal of a new population pharmacokinetics (PK) model of sorafenib and rationale for a three-daily schedule.
暂无分享,去创建一个
O. Mir | F. Goldwasser | R. Coriat | S. Barete | M. Tod | S. Ropert | B. Blanchet | P. Boudou-Rouquette | B. Billemont | N. Franck